Plain-English translation of NCT06954467 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing two medications called and , given together or separately, as a first-line treatment for advanced liver cancer. Researchers want to understand how safe and effective this medication combination is in patients whose cancer cannot be removed by surgery or local treatments. The trial will enroll up to 72 patients.
Advanced liver cancer is serious and current treatment options are limited. This trial is designed to see if the new treatment approach works better than existing options and to understand what side effects patients might experience.
You likely qualify if…
You likely don't qualify if…
The trial has two phases. First, a smaller group of 3 to 12 patients will receive the medication to test its safety and find the right dose. Then, 40 to 60 more patients will be randomly assigned to receive either the two medications together or one medication alone. Participants will receive intravenous infusions every 3 weeks and will have regular clinic visits with blood tests and imaging scans to monitor their cancer and any side effects.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
China